The global epidemic of diabetes is creating increased demands of insulin, though about a 10 millions of people cannot get injections unless they are easily accessible to them at affordable rates, a study suggests on Wednesday. The diabetes is affecting about 9% of adults worldwide, which was increased from 5% during the year 1980. Diabetes leads to many other problems such as blindness, heart problems, kidney failures, neuropathic amputations and pain. Majority of the diabetes patients found have type2 diabetes, which is caused due to increased obesity and absence of exercise, while such cases are rapidly increasing in this developing world due to urban lifestyles and adoption of western culture by people.
The researchers found that there has been a 20% increase in the demand of insulin for treating type2 diabetes over the upcoming twelve years, but the insulin will be only available to only the half of 79million patients till the year 2030. This shortfall of insulin is more serious in Africa, as the estimated supply has to be increased at a higher level to treat the patients at risk who require insulin in order to control the sugar in blood. So, these estimates prove that the present insulin available is inadequate to treat the increased demand, particularly in the Asia and Africa, Sanjay Basu of Stanford University said.
The commitment done by UN to make insulin available for treating diabetes has some issues, as the resources are scarce and inaccessible to patients. The insulin supply has been affected due to three companies—Sanofi, Eli Lilly and Novo Nordisk who carry out various programs which try to increase their reach to the people demanding for insulin. Insulin is however far from the reach of poor countries as it is very costly. The costs are increased due to indirect supply chain & increased middlemen prices.